Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Identification of genetic factors that predispose to either immune checkpoint inhibitor or conventional chemotherapy toxicity
Palles, Claire
(Principal Investigator)
Middleton, Gary
(Co-Investigator)
Steven, Neil
(Co-Investigator)
Cancer and Genomic Sciences
Immunology and Immunotherapy
Overview
Fingerprint
Research output
(2)
Research output
Research output per year
2022
2022
2023
2023
2
Article
Research output per year
Research output per year
2 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2023
Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
Payne, K.
,
Brooks, J.
,
Batis, N.
,
Khan, N.
,
El-Asrag, M.
,
Nankivell, P.
,
Mehanna, H.
&
Taylor, G.
,
9 Nov 2023
,
In:
British Journal of Cancer.
129
,
10
,
p. 1590-1598
9 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Circulating Neoplastic Cells
100%
Squamous Cell Carcinoma of Head and Neck
89%
Proteomics
74%
Epithelial-Mesenchymal Transition
27%
Single-Cell Analysis
7%
32
Downloads (Pure)
2022
Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity
Chin, I. S.
,
Khan, A.
,
Olsson-Brown, A.
,
Papa, S.
,
Middleton, G.
&
Palles, C.
,
24 Dec 2022
,
In:
NPJ Genomic Medicine.
7
,
1
,
14 p.
, 73.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Genetic Variation
100%
Autoimmune Diseases
35%
Immune System Diseases
22%
Genome-Wide Association Study
21%
Neoplasms
20%
40
Downloads (Pure)